Neratinib Options
For instance, it's been shown that high-dose CsA—although not low dose CsA—specifically inhibits the expression of NFATc1 and IL-2 in human T cells from stimulated full blood samples, assessed by circulation cytometry (23). Consequently, compared with other cytotoxic immune suppressors, CsA won't kill the immune effector cells but alternatively